Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Philips Focuses On Health Care And Lighting Business

This article was originally published in PharmAsia News

Executive Summary

As part of its ongoing transformation and restructuring, Philips has spent almost $20 billion on large-scale acquisitions in the health care and lighting sectors in recent years. Compared to the corporation's global market, Philips China has a lower ratio of health care and lighting business, thus it intends to expand the two areas. Inside sources explain that self-development will not allow the company to meet the two sectors' rapid growth, while acquisition can save time and scale up quickly. Philips will seek breakthrough in the mid- and low-end medical device market, which occupies some 75 percent of the China market. The Dutch company, GE and Siemens are leading players in the high-end medical device market. (Click here for more - Chinese language)

You may also be interested in...



Dr Reddy's Isolates Data Service Centers Among Preventive Actions Responding To Cyberattack

J&J Faces Fraud Claims From Merger With Surgical Robot Firm

Investors in surgical robotics company Auris say Johnson & Johnson failed to support the company per their merger agreement.

As Pandemic Boosts Demand For Immunity Supplements, Dentovations Launches Self+ Line

based firm, which markets Activa hand sanitizers, is offering Self+ immunity supplements in Brain, Energy and Unwind formulations in powder format for mixing with water.

UsernamePublicRestriction

Register

ID1132327

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel